Page last updated: 2024-10-22

apraclonidine and Recrudescence

apraclonidine has been researched along with Recrudescence in 2 studies

apraclonidine: relieves postoperative intraocular pressure following trabeculoplasty; RN given refers to parent cpd
apraclonidine : An imidazoline that is 2-amino 4,5-dihydro-1H-imidazoline in which one of the exocyclic amino hydrogens has been replaced by a 4-amino-2,6-dichlorophenyl group.

Research Excerpts

ExcerptRelevanceReference
"We document the recurrence of a CSMD in a patient subsequent to the instillation of topical ocular hypotensive medications and its resolution on discontinuation of therapy."1.35Recurrent serous macular detachment after topical ocular hypotensive medication. ( Besada, E; Frauens, BJ; Shechtman, D, 2008)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Besada, E1
Shechtman, D1
Frauens, BJ1
Jampel, HD1

Other Studies

2 other studies available for apraclonidine and Recrudescence

ArticleYear
Recurrent serous macular detachment after topical ocular hypotensive medication.
    Clinical & experimental optometry, 2008, Volume: 91, Issue:6

    Topics: Administration, Topical; Antihypertensive Agents; Clonidine; Drug Combinations; Drug Therapy, Combin

2008
Hypotony following instillation of apraclonidine for increased intraocular pressure after trabeculoplasty.
    American journal of ophthalmology, 1989, Aug-15, Volume: 108, Issue:2

    Topics: Aged; Clonidine; Humans; Intraocular Pressure; Male; Ocular Hypertension; Recurrence; Trabeculectomy

1989